drugset / Trial / NCT05651074

Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects

NCT05651074

NaSingle-groupOpen-labelTreatment

Summary

The primary objective of the study is to evaluate the effects of omeprazole on the PK and PD of a single dose of vicagrel in healthy subjects.

Timeline

Start
2022-11-14
Primary completion
2023-02
Completion
2023-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 40 mg
Subject SUMECIGREL Small molecule 18 mg

Indications

No indication recorded.